Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study

Last updated: April 10, 2024
Sponsor: Azienda Ospedaliera di Bolzano
Overall Status: Active - Recruiting

Phase

N/A

Condition

Orthostatic Hypotension

Dizzy/fainting Spells

Cataplexy

Treatment

Tilt Table Test

Clinical Study ID

NCT06356207
113-2023
  • Ages > 18
  • All Genders

Study Summary

Syncope is a common presenting condition. Pacemaker implantation can significantly reduce syncope recurrences in reflex syncope. However, despite careful selection, a substantial proportion of patients treated with pacemakers suffer recurrences of syncope. It is thought that a pronounced vasodepressor component may hinder the efficacy of pacing in patients, preventing adequate cerebral perfusion during the reflex, thus relativizing the anti-bradycardia function of the pacemaker to prevent syncope. It is hypothesised that the time elapsed from the actual loss of consciousness to the asystole recorded on the ECG during Tilt Table Test may be predictive in terms of response to pacemaker therapy, so this parameter becomes the subject of the present study.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients eligible for invasive treatment according to the ESC Guidelines for pacing 2021
  • Written informed consent

Exclusion

Exclusion Criteria:

  • Other condition which explains syncope cause other than reflex syncope
  • Structural heart disease (valvular, ischaemic, cardiomyopathies)
  • Pregnancy
  • Patient denial to be recorded on video during tilt table test

Study Design

Total Participants: 64
Treatment Group(s): 1
Primary Treatment: Tilt Table Test
Phase:
Study Start date:
March 20, 2024
Estimated Completion Date:
March 31, 2027

Study Description

Syncope is a common leading affection and is responsible for 1-3% of the presentations in emergency departments and up to 3% of inpatient admissions. Syncope poses often a diagnostic and therapeutic challenge for the attending physician and is often misdiagnosed or underdiagnosed. Patients can be treated with pacemaker implantation when the syncope cause is a cardioinhibition with documented asystole during the syncopal event. When accurately selected, patients benefit from pacemaker therapy with a significant reduction of syncope recurrence in the follow up. However, a substantial portion of the patients (approx. 25%) experience recurrence of syncope despite optimal pacemaker therapy. The underlying mechanism is not well understood and object of the current study.

The main target of the study is to evaluate the time elapsed between the T-LOC during Video Tilt Table Testing and the asystole at the ECG using a registry and to assess its predictive value in patients undergoing invasive treatment. The hypothesis is that a vasodepressive component could lessen the effect of pacing in a patient, leading to cerebral hypoperfusion and syncope despite maintaining a stable rhythm.

This is a prospective, multi-center observational study with 2 year follow-up of patients. Patients eligible for invasive treatment of reflex syncope are included.

If after guideline-directed implantable loop recorder insertion no cardioinhibition has been recorded, the patient is included automatically in the registry.

Connect with a study center

  • Azienda Sanitaria di Bolzano

    Bolzano, 39100
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.